The results may be compelling enough to get insurance companies to provide coverage, said Dr. Shauna Levy, a specialist in obesity medicine and the medical director of the Tulane Bariatric Center in New Orleans.
“Twenty percent is huge,” Levy said. “All of this narrative about people just wanting this for cosmetic reasons, I think, to some degree, has overshadowed all of the health benefits we can get from this medication.”The findings were based on a late-stage clinical trial of more than 17,000 adults ages 45 and up who got a 2.4-milligram dose of Wegovy or a placebo in addition to standard care.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wegovy Reduces Risk of Heart Attack and Stroke in Major Cardiovascular TrialA major clinical trial has shown that the weight loss drug Wegovy can reduce the risk of heart attack, stroke, or heart disease-related death by 20% in people with cardiovascular disease, marking the first time a weight loss drug has demonstrated such protective effects.
Source: CNN - 🏆 4. / 95 Read more »
Source: Reuters - 🏆 2. / 97 Read more »